Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

Clin Infect Dis. 2014 Jan;58(1):117-20. doi: 10.1093/cid/cit672. Epub 2013 Oct 2.

Abstract

In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Keywords: HIV; MSM; antiretroviral; new diagnosis; self-report.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-Retroviral Agents / blood*
  • Anti-Retroviral Agents / therapeutic use
  • HIV / isolation & purification*
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Mass Spectrometry / methods
  • Middle Aged

Substances

  • Anti-Retroviral Agents